Connect with us

Hi, what are you looking for?

Arterial Blood Gas Kits Market: Increasing Prevalence of Respiratory Diseases

According to The Insight Partners new research study on “Arterial Blood Gas Kits Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by product type, end-user,” the market is expected to reach US$ 773.01 million in 2028 from US$ 455.84 million in 2021 growing at a CAGR of 7.8% from 2021-2028. An arterial blood gas (ABG) is a blood test carried out by taking blood from an artery, rather than a vein.

It is performed so that an accurate measurement of oxygen and carbon dioxide levels can be obtained, which then allows the patients oxygen to be delivered appropriately. The kit includes a needle protection sheath that cores the bevel and encapsulates the contaminated needle to prevent blood spatter. The integral safety clips on the syringe allows for audible and visual confirmation that the needle is secure. Syringes are available non-vented or with a rear vented system which automatically evacuates air out the back of the syringe as the blood fills during the draw. Arterial blood gas tests are also performed on patients in respiratory distress, such as an asthma attack.

Download sample PDF Copy at:

Becton Dickinson and Company, Radiometer Medical ApS, Smiths Medical, Vyaire Medical, Opti Medical Systems, Inc., Westmed Medical, Siemens Healthineers AG, ITL Biomedical, i-SENS, Inc., and Teleflex Incorporated amongst others.

The companies are adopting inorganic and organic growth strategies to expand their global footprints and product portfolio to meet the rising demands for the Arterial Blood Gas Kits. For instance, in Jan 2020, Siemens Healthineers has received U.S. Food and Drug Administration approval for RAPIDPoint 500e Blood Gas System. RAPIDLyte Arterial Sampling Syringes and RAPIDLyte Multicap Capillaries offered by the Siemens are compatible to use with RAPIDPoint 500e Blood Gas System. This product approval will strengthen the market position of the company.

Arterial Blood Sampling syringes utilize lithium heparin with a concentration of 23.5 I.U. per mL. The specially formulated dry lithium heparin provides the necessary anticoagulation along with minimal interference for more accurate and consistent results. The syringes are available with a broad choice of product features. There are various types of 1 ml syringe volume which has different features. For instance, Thermo Fishers Smiths Medical Pro-Vent Plus provides arterial Blood Sampling syringes utilize dry lithium heparin with a low concentration of 7 I.U. per mL. The low heparin concentration allows for healthcare professionals to obtain very small blood samples and still maintain the full range of blood gas, electrolyte, and metabolite testing with reduced heparin interference and extended clotting time.

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns.

Download the Latest COVID-19 Analysis on Arterial Blood Gas Kits Market Growth Research Report at:

Based on product type, the arterial blood gas kits market is segmented into 1ml (syringe volume), 3ml (syringe volume), and others. The 3ml (syringe volume) segment is likely to hold largest share of the market in 2021, also the same segment is anticipated to register the highest CAGR of 8.2% in the market during the forecast period.

Based on the end user, the arterial blood gas kits market is segmented into hospitals, clinics, and others. In 2021, hospitals segment is likely to hold largest share of the market whereas clinics segment is estimated to register the highest CAGR of 8.4% in the market during the forecast period.

Huge population suffers from the various types of respiratory diseases across the world. Smoking, infections, and genetic factors can cause respiratory diseases. Chronic obstructive pulmonary disease (COPD), asthma, and pneumonia are a few medical conditions exerting a huge burden on the public healthcare system in various countries worldwide. The American Lung Association reported that COPD is the third leading cause of death in the US, where over 16.4 million people are diagnosed with the condition.

Order a Copy of Arterial Blood Gas Kits Market Shares, Strategies and Forecasts 2021-2028 Research Report at:

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: [email protected]

Phone: +1-646-491-9876

Press Release:


Written By

You may also like:

Tech & Science

The United Arab Emirates, which has launched a bold Mars mission, now hopes to become a pioneer in the depths of the metaverse.

Tech & Science

With the help of high-resolution satellite observations, scientists detail the unique pattern of sea level change linked to the Greenland ice sheet.


A tie-up between Vodafone and Three UK would create the biggest player in the UK mobile industry - Copyright AFP/File Roslan RAHMANVodafone on Monday...